Browse Category

NASDAQ:TVTX News 6 January 2026 - 13 January 2026

Ligand Pharmaceuticals stock slides as FDA pushes back Travere’s Filspari decision to April 13

Ligand Pharmaceuticals stock slides as FDA pushes back Travere’s Filspari decision to April 13

NEW YORK, Jan 13, 2026, 14:32 (EST) — Regular session Shares of Ligand Pharmaceuticals Incorporated dropped 10.6% to $184.80 in Tuesday afternoon trading. The decline followed an announcement from royalty partner Travere Therapeutics that U.S. regulators extended the review period for its Filspari application, pushing the decision date to April 13. Travere said the FDA classified its latest submission as…
Travere Therapeutics stock slides as FDA pushes Filspari FSGS decision into April

Travere Therapeutics stock slides as FDA pushes Filspari FSGS decision into April

New York, January 13, 2026, 14:17 (EST) — Regular session Shares of Travere Therapeutics (TVTX.O) dropped 19% to $27.56 in early afternoon trading Tuesday after the U.S. Food and Drug Administration extended its review of the kidney drug Filspari for broader use. The stock had fallen as much as 34% earlier, hitting a low of $22.35. (Reuters) The delay comes…
Travere Therapeutics TVTX stock slides 5% as FDA decision on Filspari nears

Travere Therapeutics TVTX stock slides 5% as FDA decision on Filspari nears

New York, January 6, 2026, 15:27 (ET) — Regular session Nasdaq-listed Travere Therapeutics shares fell 5.3% to $36.09 in afternoon trading on Tuesday as investors looked toward next week’s U.S. FDA decision deadline on expanding its kidney drug Filspari (sparsentan) into focal segmental glomerulosclerosis. The FDA’s Prescription Drug User Fee Act, or PDUFA, target action date is Jan. 13, and…

Stock Market Today

  • European Markets Set for Higher Open Amid Busy Earnings Week
    January 27, 2026, 1:37 AM EST. European stocks are forecast to open higher Tuesday, with the U.K.'s FTSE up 0.18%, Germany's DAX 0.15%, France's CAC 40 0.3%, and Italy's FTSE MIB 0.4%, ahead of key earnings reports from ASML, Volvo, LVMH, and Deutsche Bank. Tuesday brings results from Atlas Copco, Sandvik, and Logitech International. Global trade tensions simmer as U.S. President Donald Trump threatens increased tariffs on South Korean goods, roiling markets. S&P 500 futures remain near flat despite the upbeat start to earnings season. Investors await the Federal Reserve's rate decision, with the rate expected to hold at 3.5%-3.75%, seeking signals on future cuts. European economic data includes EU car registrations, Spanish unemployment, and French consumer confidence.
Go toTop